Table 2 Adjusted vaccine effectiveness of inactivated Covid-19 vaccine against Covid-19 outcomes

From: Effectiveness of inactivated COVID-19 vaccines among older adults in Shanghai: retrospective cohort study

 

Unvaccinated (N = 3,317,475)

Vaccinated (N = 3,317,475)

Risk difference per million PWs (95% CI)

VE (95% CI)

 

Events

Risk per million PWs

Events

Risk per million PWs

Outcome 1: Documented SARS-CoV-2 infection

Overall

48,447

436.1

36,581

328.8

107.3 (106.8, 107.8)

24.7 (23.7, 25.7)

Age group—no.

 60–69 years old

32,458

437.2

25,124

337.9

99.3 (98.7, 99.9)

22.8 (21.5, 24.0)

 70–79 years old

13,332

423.7

9849

312.5

111.2 (110.2, 112.2)

26.4 (24.5, 28.3)

 80–89 years old

2501

481.5

1532

294.2

187.3 (183.2, 191.4)

38.9 (34.9, 42.7)

 90 years old and above

156

794.8

76

385.3

409.6 (371.4, 447.6)

52.1 (37.0, 63.6)

Sex—no. (%)

 Male

23,800

427

18,288

327.6

99.4 (98.7, 100.1)

23.4 (21.9, 24.9)

 Female

24,647

445.2

18,293

329.9

115.3 (114.5, 116.1)

25.9 (24.5, 27.4)

Chronic disease—no.

 0

27,738

433.9

22,001

343.7

89.6 (89.0, 90.1)

20.9 (19.5, 22.3)

 ≥1

20,709

439.1

14,580

308.5

129.4 (128.5, 130.4)

29.8 (28.2, 31.3)

Outcome 2: Severe/critical Covid-19

Overall

601

5.4

81

0.7

4.7 (4.4, 5.0)

86.6 (83.1, 89.4)

Age group—no. (%)

 60–69 years old

250

3.4

20

0.3

3.1 (2.8, 3.4)

91.8 (87.1, 94.8)

 70–79 years old

201

6.4

39

1.2

5.2 (4.7, 5.6)

80.7 (72.7, 86.3)

 80–89 years old

135

26.0

18

3.5

22.5 (19.7, 25.3)

86.7 (78.3, 91.9)

 90 years old and above

15

76.4

4

20.3

56.1 (37.3, 74.1)

73.6 (20.4, 91.2)

Sex—no. (%)

 Male

184

3.3

24

0.4

2.9 (2.6, 3.2)

86.8 (79.8, 91.4)

 Female

417

7.5

57

1.0

6.5 (6.0, 7.0)

86.5 (82.2, 89.8)

Chronic disease—no.

 0

269

4.2

32

0.5

3.7 (3.4, 4.0)

88.1 (82.9, 91.8)

 ≥1

332

7.0

49

1.0

6.0 (5.5, 6.5)

85.4 (80.2, 89.2)

Outcome 3: Covid-19-related death

Overall

190

1.7

13

0.1

1.6 (1.4, 1.8)

93.2 (88.0, 96.1)

Age group—no. (%)

 60–69 years old

64

0.9

2

0.0

1.2 (0.9, 1.4)

96.8 (87.0, 99.2)

 70–79 years old

67

2.1

7

0.2

2.0 (1.7, 2.3)

89.5 (77.1, 95.2)

 80–89 years old

52

10.0

3

0.6

1.2 (0.9, 1.4)

94.2 (81.5, 98.2)

 90 years old and above

7

35.7

1

5.1

2.0 (1.7, 2.3)

85.8 (−15.5, 98.3)

Sex—no.

 Male

68

1.2

3

0.1

1.1 (0.9, 1.3)

95.6 (86.1, 98.6)

 Female

122

2.2

10

0.2

2.0 (1.7, 2.3)

91.8 (84.3, 95.7)

Chronic disease—no. (%)

 0

108

1.7

3

0.0

1.6 (1.4, 1.9)

97.2 (91.3, 99.1)

 ≥1

82

1.7

10

0.2

1.5 (1.3, 1.8)

87.8 (76.3, 93.7)

  1. 95% CI 95% confidence interval, PW person-weeks, NA not available.
  2. Vaccine effectiveness was adjusted by presence of comorbidities of cancer, hypertension, or diabetes.